Page 3 - Peterson Alva News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Alkermes Announces the Appointment of Emily Peterson Alva to its Board of Directors
DUBLIN, May 20, 2021 /PRNewswire/ Alkermes plc (Nasdaq: ALKS) today announced the appointment of a new independent director, Emily Peterson Alva, to the company s Board of Directors ( Board ). Emily Peterson Alva is an experienced public company board member and a financial, strategic and business advisor to growth companies. A former Lazard M&A Partner with more than 15 years of investment banking experience, Ms. Alva brings significant experience navigating complex strategic, transactional and governance matters for public companies across many sectors including specific expertise in healthcare and pharmaceuticals.
I am delighted to welcome Emily to Alkermes Board of Directors and look forward to her insights and perspectives as we focus our efforts on high return-on-investment opportunities that are consistent with our long-term growth strategy, said Richard Pops, Chief Executive Of ....

New York , United States , Columbia University , Katie Joyce , Emily Peterson Alva , Sandy Coombs , Nasdaq Center , Ey Audit Committee Leaders , Council On Foreign Relation Corporate Leaders Program , Financial Operating Committee , Exchange Commission , Atlanta Life Insurance Company , Boards Of Directors Amneal Pharmaceuticals Inc , Herndon Directors Institute , Barnard College , Alkerme Board , Richard Pops , Chief Executive Officer , Alkermes Board , Elliott Advisors , Value Enhancement Plan , Peterson Alva , Amneal Pharmaceuticals , Emission Society , Board Excellence , Nextgen Board Leaders ,